DELSTRIGO

doravirine/lamivudine/tenofovir disoproxil fumarate 100 mg/300 mg/300 mg tablets

Before prescribing DELSTRIGO, please read the accompanying Prescribing Information, including the Boxed Warning about posttreatment acute exacerbation of Hepatitis B.

DELSTRIGOTM (doravirine/​lamivudine/​tenofovir disoproxil fumarate) is now FDA approved

View press release
Vouchers & Coupons

Eligible health care professionals may request available vouchers and/or coupons for DELSTRIGO for use with their appropriate patients.

Request vouchers and/or coupons
US-DOR-0006805/19